SCHEMBL742544

SCHEMBL742544

COCCOC(C)OC(C)OCCOC

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL891898 0.88 LMNA (0.42) PIK3CDLMNA
SCHEMBL8797154 0.85
SCHEMBL20213372 0.84
SCHEMBL17789988 0.83 CA2 (0.31)
SCHEMBL669602 0.82
SCHEMBL20641609 0.82
SCHEMBL20213371 0.81
SCHEMBL891978 0.80 LMNA (0.36) PIK3CDLMNA
SCHEMBL11442338 0.80 LMNA (0.36) PIK3CDLMNA
SCHEMBL892322 0.78 LMNA (0.63) PIK3CDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110564151-A Polyimide composition and polyimide film 株式会社东进世美肯 2019-12-13 CN claimed
US-4270365-A Refrigeration apparatus SAMPIETRO ACHILLES C 1981-06-02 US claimed
US-12042479-B2 Use of topical formulations of cannabinoids in the treatment of epidermolysis bullosa and related connective tissue disorders INMED PHARMACEUTICALS INC. 2024-07-23 US disclosed
CN-106947080-B Composition for preparing polyimide film, preparation method thereof and preparation method of polyimide film using composition 东进世美肯株式会社 2024-02-23 CN disclosed
CN-110872438-B Polyamic acid-imide composition, preparation method thereof and polyimide film 株式会社东进世美肯 2024-01-05 CN disclosed
US-20230381205-A1 COMPOSITIONS AND METHODS FOR TREATING NEURONAL DISORDERS WITH CANNABINOIDS INMED PHARMACEUTICALS INC. (CA) 2023-11-30 US disclosed
CN-117136050-A Compositions and methods for treating neuronal disorders using cannabinoids 因美制药公司 2023-11-28 CN disclosed
CN-117063124-A Method for manufacturing flexible printed board 株式会社钟化 2023-11-14 CN disclosed
CN-116997856-A Method for manufacturing flexible printed board 株式会社钟化 2023-11-03 CN disclosed
CN-115918275-B Method for manufacturing flexible printed board 株式会社钟化 2023-10-27 CN disclosed
CN-115918275-A Method for manufacturing flexible printed board 株式会社钟化 2023-04-04 CN disclosed
EP-0294931-B1 SELF-LUBRICATING THERMOSETTING RESIN COMPOSITION MITSUI TOATSU CHEMICALS, Inc. (JP) 1992-09-02 EP disclosed
EP-0486479-A2 Thermosetting resin composition MITSUI TOATSU CHEMICALS, Inc. (JP) 1992-05-20 EP disclosed
US-5112899-A Bismaleimide, Diamine, Glass or Carbon Fibers MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1992-05-12 US disclosed
US-5049606-A Polyaminobismaleimide resin and fluorescein MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1991-09-17 US disclosed
EP-0294931-A1 Self-lubricating thermosetting resin composition MITSUI TOATSU CHEMICALS, Inc. (JP) 1988-12-14 EP disclosed
EP-0288251-A1 Thermosetting resin composition MITSUI TOATSU CHEMICALS, Inc. (JP) 1988-10-26 EP disclosed
US-4270365-A Refrigeration apparatus SAMPIETRO ACHILLES C 1981-06-02 US disclosed
US-4270365-A Refrigeration apparatus SAMPIETRO ACHILLES C 1981-06-02 US disclosed
US-4014867-A IN COPPER CHROMITE ALLIED CHEMICAL CORPORATION (US) 1977-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381205-A1 COMPOSITIONS AND METHODS FOR TREATING NEURONAL DISORDERS WITH CANNABINOIDS CNR2, CNR1, GAP43 PIK3CD 815/4885LMNA 2505/4885
US-12042479-B2 Use of topical formulations of cannabinoids in the treatment of epidermolysis bullosa and related connective tissue disorders KRT18, DSP, DSC1 PIK3CD 3445/4885LMNA 125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.